<p>The present invention relates to the use of a vitamin D compound active in up-regulating the expression and production of hCAP18 in humans for the manufacture of a medicament for treatment of conditions deficient in or benefiting from LL-37. The vitamin D active compound can be used as a medicament for treatment of injured tissues, chronic ulcers, burn wounds, skin infections and atopic dermatitis and for improving the microvasculature. UVB irradiation can also be used to up-regulate hCAP18.</p>
申请公布号
WO2006011849(A1)
申请公布日期
2006.02.02
申请号
WO2005SE01184
申请日期
2005.07.26
申请人
LIPOPEPTIDE AB;STAAHLE, MONA;WEBER, GUENTHER;HEILBORN, JOHAN